Review



receptor gamma 2  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Bioss receptor gamma 2
    Receptor Gamma 2, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/GABA+A+Receptor+gamma+2+Antibody/pmc12513486__jciinsight-10-193119-s227-10-17-25
    Average 93 stars, based on 7 article reviews
    receptor gamma 2 - by Bioz Stars, 2026-09
    93/100 stars

    Images



    Similar Products

    86
    Jackson Laboratory immunodeficient nod scid il 2 receptor common gamma chain deficient nsg mice
    Immunodeficient Nod Scid Il 2 Receptor Common Gamma Chain Deficient Nsg Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/mice+ob+ob/pmc12864042-499-0-11
    Average 86 stars, based on 1 article reviews
    immunodeficient nod scid il 2 receptor common gamma chain deficient nsg mice - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    94
    OriGene human gaba a receptor γ2
    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) <t>GABA</t> <t>A</t> receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of <t>γ2</t> and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .
    Human Gaba A Receptor γ2, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/GABA+A+Receptor+gamma+2+(GABRG2)+(NM_000816)+Human+Tagged+ORF+Clone/pmc12834500-13-7-16
    Average 94 stars, based on 1 article reviews
    human gaba a receptor γ2 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    Jackson Laboratory nod scid interleukin 2 receptor gamma null nsg mice
    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) <t>GABA</t> <t>A</t> receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of <t>γ2</t> and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .
    Nod Scid Interleukin 2 Receptor Gamma Null Nsg Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/mice+nsg/pmc12716143-110-3-13
    Average 86 stars, based on 1 article reviews
    nod scid interleukin 2 receptor gamma null nsg mice - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    PhosphoSolutions γ2 anti alpha 5 antibody phosphosolutions cat no 846a ga5c anti gamma 2 antibody novus cat no nb300 190
    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) <t>GABA</t> <t>A</t> receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of <t>γ2</t> and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .
    γ2 Anti Alpha 5 Antibody Phosphosolutions Cat No 846a Ga5c Anti Gamma 2 Antibody Novus Cat No Nb300 190, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/Anti-GABAA+Receptor+%CE%B15+Antibody/pmc12764511-97-19-22
    Average 96 stars, based on 1 article reviews
    γ2 anti alpha 5 antibody phosphosolutions cat no 846a ga5c anti gamma 2 antibody novus cat no nb300 190 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    R&D Systems anti gaba a receptor gamma 2 antibody
    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) <t>GABA</t> <t>A</t> receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of <t>γ2</t> and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .
    Anti Gaba A Receptor Gamma 2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/GABA-A+R+gamma+2+Antibody/pmc12648294-161-30-35
    Average 90 stars, based on 1 article reviews
    anti gaba a receptor gamma 2 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    86
    Invivoscribe Inc t cell receptor gamma gene rearrangement assay 2 0
    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) <t>GABA</t> <t>A</t> receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of <t>γ2</t> and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .
    T Cell Receptor Gamma Gene Rearrangement Assay 2 0, supplied by Invivoscribe Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/assay+cdx+flt3+leukostrat+mutation/10__1093_slash_clinchem_slash_hvaf086__606-38-21-20
    Average 86 stars, based on 1 article reviews
    t cell receptor gamma gene rearrangement assay 2 0 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    93
    Bioss receptor gamma 2
    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) <t>GABA</t> <t>A</t> receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of <t>γ2</t> and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .
    Receptor Gamma 2, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/GABA+A+Receptor+gamma+2+Antibody/pmc12513486__jciinsight-10-193119-s227-10-17-25
    Average 93 stars, based on 1 article reviews
    receptor gamma 2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Bioss bs 4112r
    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) <t>GABA</t> <t>A</t> receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of <t>γ2</t> and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .
    Bs 4112r, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/receptor+gamma+2/GABA+A+Receptor+gamma+2+Antibody/pmc12513486__jciinsight-10-193119-s227-10-24-25
    Average 93 stars, based on 1 article reviews
    bs 4112r - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of γ2 and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .

    Journal: eLife

    Article Title: Phenylhydrazone-based endoplasmic reticulum proteostasis regulator compounds with enhanced biological activity

    doi: 10.7554/eLife.107000

    Figure Lengend Snippet: ( A ) Representative immunoblot (above) of HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with the indicated AA263 analog (10 µM). Quantification of band intensities (below) for cells treated with AA263 yne or AA263-5 is shown. ( B ) Immunoblot and quantification of γ2 and BiP in lysates prepared on HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with AA263 yne (10 µM) and/or Ceapin-A7 (CP7; 10 µM). ( C ) Immunoblot showing the intensity of γ2 over time following cycloheximide (CHX)-chase application (0–4 hr, 100 μg/ml) in HEK293T cells transiently transfected with α1β2γ2(WT) receptors (top) and HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with vehicle (middle) or AA263 yne (bottom). ( D ) Representative immunoblot showing total γ2 expression in HEK293T cells stably expressing α1β2γ2(R177G) receptor variant treated with indicated AA263 yne analogs (10 µM, 24 hr). One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. See also and . Figure 5—figure supplement 1—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—figure supplement 1—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—figure supplement 1—source data 3. Uncropped gels shown in .

    Article Snippet: Recombinant DNA reagent , pCMV6 plasmids containing human GABA A receptor γ2 (isoform 2) subunits , Origene , Uniprot No. P18507-2 , .

    Techniques: Western Blot, Stable Transfection, Expressing, Transfection, Variant Assay

    ( A ) Representative immunoblot (above) and quantification (below) of surface biotinylated γ2 in HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with 10 µM AA263 yne or AA263-5. Na + /K + ATPase serves as a loading control. ( B ) Representative immunoblot showing surface γ2 expression in HEK293T cells transiently transfected with α1β2γ2(R177G) receptors and treated with indicated AA263 analogs 10 µM, 24 hr. Na + /K + ATPase serves as a loading control. ( C ) Representative evoked inhibitory postsynaptic current (eIPSC) traces for α1β2γ2(WT) GABA A receptors and α1β2γ2(R177G) GABA A receptors treated for 24 hr with DMSO, AA263 yne (10 µM), or AA263-20 (10 µM). 10 mM GABA (saturating condition) was applied to the recorded cells to evoke currents. Histograms showing changes in eIPSC peak amplitude ( D ) and peak current density ( E ) for the indicated groups. Band intensities were quantified using ImageJ software, normalized to the DMSO control condition. Each data point is reported as mean ± SEM. One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis for A and B. Kruskal–Wallis test followed by post hoc Dunn’s test was used for statistical analysis for D and E. *p < 0.05; **p < 0.01; ***p < 0.001. See also and . Figure 5—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—source data 3. Uncropped gels shown in .

    Journal: eLife

    Article Title: Phenylhydrazone-based endoplasmic reticulum proteostasis regulator compounds with enhanced biological activity

    doi: 10.7554/eLife.107000

    Figure Lengend Snippet: ( A ) Representative immunoblot (above) and quantification (below) of surface biotinylated γ2 in HEK293T cells stably expressing α1β2γ2(R177G) GABA A receptors treated for 24 hr with 10 µM AA263 yne or AA263-5. Na + /K + ATPase serves as a loading control. ( B ) Representative immunoblot showing surface γ2 expression in HEK293T cells transiently transfected with α1β2γ2(R177G) receptors and treated with indicated AA263 analogs 10 µM, 24 hr. Na + /K + ATPase serves as a loading control. ( C ) Representative evoked inhibitory postsynaptic current (eIPSC) traces for α1β2γ2(WT) GABA A receptors and α1β2γ2(R177G) GABA A receptors treated for 24 hr with DMSO, AA263 yne (10 µM), or AA263-20 (10 µM). 10 mM GABA (saturating condition) was applied to the recorded cells to evoke currents. Histograms showing changes in eIPSC peak amplitude ( D ) and peak current density ( E ) for the indicated groups. Band intensities were quantified using ImageJ software, normalized to the DMSO control condition. Each data point is reported as mean ± SEM. One-way ANOVA followed by post hoc Dunnett’s test was used for statistical analysis for A and B. Kruskal–Wallis test followed by post hoc Dunn’s test was used for statistical analysis for D and E. *p < 0.05; **p < 0.01; ***p < 0.001. See also and . Figure 5—source data 1. Excel spreadsheet showing raw data used to generate . Figure 5—source data 2. Uncropped gels shown in with the same annotations shown in . Figure 5—source data 3. Uncropped gels shown in .

    Article Snippet: Recombinant DNA reagent , pCMV6 plasmids containing human GABA A receptor γ2 (isoform 2) subunits , Origene , Uniprot No. P18507-2 , .

    Techniques: Western Blot, Stable Transfection, Expressing, Control, Transfection, Software